UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
‘Allow hospitals to charge fees for AI’s data reading’
Korea needs to introduce “medical fee charging system for artificial intell...
by Kwak Sung-sun
|
2017-05-26 14:42
라인
Ultrasonic image diagnostic device was No. 1 export item last year
Korea’s medical equipment exports totaled $2.92 billion (3.26 trillion won)...
by Marian Chu
|
2017-05-26 12:50
라인
Medical workers exposed to various abuses
Six out of 10 medical workers have experienced verbal abuse from patients, ...
by Choi Gwang-seok
|
2017-05-26 10:58
라인
‘You can trust hospital chosen by a doctor like me’
"I am a senior professor at a university hospital but have suffered unimagi...
by Constance Williams
|
2017-05-25 19:20
라인
2 years after MERS, Korea still struggles with public health system
Two years have passed since the Middle East Respiratory Syndrome (MERS) thr...
by Choi Gwang-seok
|
2017-05-25 16:13
라인
Symposium discusses 4th industrial revolution in medical field
With the advent of new technology that augments human abilities, many are t...
by Constance Williams
|
2017-05-25 15:16
라인
Patent war looming over genome editing tech
The recent U.S. ruling regarding the patent dispute over the original techn...
by Nam Doo-hyun
|
2017-05-25 14:12
라인
Green Cross pushes for early FDA approval of its immunoglobulin product
The Korean pharmaceutical industry is watching with interest whether Green ...
by Lee Hye-seon
|
2017-05-25 11:01
라인
Gilead launches new, improved hepatitis B drug
Gilead has released a new hepatitis B drug, Vemlidy (ingredient: tenofovir ...
by Marian Chu
|
2017-05-25 10:29
라인
Herb doctor dupe diabetics into taking charcoal-powdered drugs for 8 years
An oriental medicine doctor has finally received a verdict of guilty, for p...
by Choi Gwang-seok
|
2017-05-24 18:19
라인
Hanmi ranked No. 1 in R&D investment
Hanmi Pharmaceuticals spent the largest amount of money on research and inv...
by Lee Hye-seon
|
2017-05-24 14:19
라인
Korean drugmakers challenge Pfizer’s smoking cessation therapy Champix
Korea’s drugmakers are challenging Champix (compound: Varenicline tartrate)...
by Lee Hye-seon
|
2017-05-24 13:16
라인
FDA approves 1st cancer drug for tumors with particular genetic feature
Merck & Co has won an accelerated approval from the U.S. Food and Drug Admi...
by Marian Chu
|
2017-05-24 12:37
라인
Rising demand for cosmeceuticals forces pharmaceuticals to jump into cosmetics market
Domestic pharmaceutical companies are competing to jump into the cosmetics ...
by Constance Williams
|
2017-05-24 11:35
라인
Is Asia ready for digital transformation in healthcare?
Nearly eight out of 10 healthcare industry insiders believe that healthcare...
by Marian Chu
|
2017-05-24 11:07
라인
Can ‘cloud tech’ revolutionize healthcare?
Cloud computing is now widely accepted by healthcare organizations worldwid...
by Constance Williams
|
2017-05-24 09:41
라인
Southwestern region plagued by oriental medicine hospitals
Oriental medicine hospitals have been steadily increasing in Gwangju Metrop...
by Choi Gwang-seok
|
2017-05-23 17:59
라인
Korea, US university hospitals to cooperate in digital healthcare
The Chung-Ang University Hospital held an international symposium jointly w...
by Constance Williams
|
2017-05-23 11:16
라인
Approvals of incrementally modified drugs poured in last year
Korean pharmaceutical companies are now actively developing incrementally m...
by Lee Hye-seon
|
2017-05-23 10:55
라인
Ildong confident of its hepatitis drug surviving market competition
Ildong Pharmaceuticals is preparing to launch its chronic hepatitis B drug,...
by Marian Chu
|
2017-05-23 10:33
-
이전
311
312
313
314
315
316
317
318
319
320
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top